ReviewCurrent genomics2025
The Bacterial Role in the Progression of Breast Cancer through Mechanism of Gene Action: Future Prospects with Existing Studies.
Review in Current genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer is the main cause of death for women, even with major improvements in treatment. Through processes like DNA damage, estrogen metabolism, and immunological regulation, bacterial populations have been shown to have an impact on breast cancer development in recent studies. Objectives: This review aimed to examine and evaluate current research on the involvement of bacteria in breast cancer progression, with an emphasis on gene action mechanisms and potential future treatments targeting the microbiome. Methods: A thorough literature analysis was carried out to identify pertinent research published between 1989-2024 across various databases, including PubMed, Google Scholar, Google, and Scopus. Results: Bacterial dysbiosis in the gut and breast tissue contributes to the progression of breast cancer through different pathways. Double-strand breaks in DNA are linked to various bacteria, like Conclusion: Bacteria contribute significantly to the development of breast cancer through gene-level processes. Probiotics, immunomodulatory techniques, and microbiome-targeted treatments are potential future developments that could improve therapy effectiveness and reduce resistance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.